Search Course Outline

Search

Showing 25 course outlines from 19204 matches

10326

MEDSCI 318

: Pharmacokinetics and Drug Toxicity
2025 Semester One (1253)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
10327

MEDSCI 318

: Pharmacokinetics and Drug Toxicity
2024 Semester One (1243)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
10328

MEDSCI 318

: Pharmacokinetics and Drug Toxicity
2023 Semester One (1233)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
10329

MEDSCI 318

: Pharmacokinetics and Drug Toxicity
2022 Semester One (1223)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
10330

MEDSCI 318

: Pharmacokinetics and Drug Toxicity
2021 Semester One (1213)
Considers the biochemical processes involved in achieving clinically-relevant drug concentrations that result in therapeutic effects and drug toxicity, from drug input, distribution, and elimination plus the ways in which these processes are described (pharmacokinetic modelling). Explores factors such as drug-drug interactions, pharmacogenetics, dosing and pharmacokinetic considerations in selected populations and that may influence both clinical effectiveness and drug toxicity.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 303, 306, 321
10331

MEDSCI 319

: Molecular Pharmacology
2025 Semester One (1253)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
10332

MEDSCI 319

: Molecular Pharmacology
2024 Semester One (1243)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
10333

MEDSCI 319

: Molecular Pharmacology
2023 Semester One (1233)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
10334

MEDSCI 319

: Molecular Pharmacology
2022 Semester One (1223)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
10335

MEDSCI 319

: Molecular Pharmacology
2021 Semester One (1213)
Explores the cellular and molecular mechanisms of drug action with a focus on G-protein coupled receptors and biochemical targets for cancer therapy. Drug design is considered from the perspective of in silico modelling, biochemical assessment and intracellular signalling.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, BIOSCI 203
Restriction: MEDSCI 304, 321
10336

MEDSCI 320

: Pharmacology of the Brain and Body
2025 Semester Two (1255)
Extends the principles of pharmacology acquired at Stage II to discuss how diseases can be treated in a variety of organ systems including the cardiovascular, gastrointestinal, endocrine, reproductive, and respiratory systems with emphasis on the central nervous system. Covers the mechanisms of action of drugs, and the influence of anatomy, physiology and pathology.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, 206, BIOSCI 203
Restriction: MEDSCI 305, 307
10337

MEDSCI 320

: Pharmacology of the Brain and Body
2024 Semester Two (1245)
Extends the principles of pharmacology acquired at Stage II to discuss how diseases can be treated in a variety of organ systems including the cardiovascular, gastrointestinal, endocrine, reproductive, and respiratory systems with emphasis on the central nervous system. Covers the mechanisms of action of drugs, and the influence of anatomy, physiology and pathology.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, 206, BIOSCI 203
Restriction: MEDSCI 305, 307
10338

MEDSCI 320

: Pharmacology of the Brain and Body
2023 Semester Two (1235)
Extends the principles of pharmacology acquired at Stage II to discuss how diseases can be treated in a variety of organ systems including the cardiovascular, gastrointestinal, endocrine, reproductive, and respiratory systems with emphasis on the central nervous system. Covers the mechanisms of action of drugs, and the influence of anatomy, physiology and pathology.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, 206, BIOSCI 203
Restriction: MEDSCI 305, 307
10339

MEDSCI 320

: Pharmacology of the Brain and Body
2022 Semester Two (1225)
Extends the principles of pharmacology acquired at Stage II to discuss how diseases can be treated in a variety of organ systems including the cardiovascular, gastrointestinal, endocrine, reproductive, and respiratory systems with emphasis on the central nervous system. Covers the mechanisms of action of drugs, and the influence of anatomy, physiology and pathology.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, 206, BIOSCI 203
Restriction: MEDSCI 305, 307
10340

MEDSCI 320

: Pharmacology of the Brain and Body
2021 Semester Two (1215)
Extends the principles of pharmacology acquired at Stage II to discuss how diseases can be treated in a variety of organ systems including the cardiovascular, gastrointestinal, endocrine, reproductive, and respiratory systems with emphasis on the central nervous system. Covers the mechanisms of action of drugs, and the influence of anatomy, physiology and pathology.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from MEDSCI 203, 205, 206, BIOSCI 203
Restriction: MEDSCI 305, 307
10341

MEDSCI 321

: Special Topic: Concepts in Pharmacology
2022 Semester One (1223)
Explores the cellular and molecular mechanisms of drug action plus drug discovery and development from the perspective of in silico modelling, biochemical assessment, intracellular signalling and human disease. Considers the pharmacokinetic processes of input, distribution and elimination involved in achieving clinically-relevant drug concentrations. Describes the link between concentration and effect and the time course of effect. Explores factors such as disease progression, drug metabolism, drug-drug interactions, pharmacogenetics, use in selected populations and in various pathological conditions that may influence both clinical effectiveness and drug toxicity.
Subject: Medical Science
Prerequisite: MEDSCI 204 and 30 points from BIOSCI 203, MEDSCI 203, 205
Restriction: MEDSCI 303, 306, 318, 319, 735
10342

MEDSCI 700

: Drug Discovery Biology
2025 Semester One (1253)
Reviews recent studies on the use of chemical and genetic methods to characterise the role of proteins in disease and their potential as drug targets. Topics will include proteins involved in regulation of immune response, lipid mediated cell signalling pathways, drug-protein interactions, some discovery methods, and pre-clinical studies on mechanism of action.
Subject: Medical Science
No pre-requisites or restrictions
10343

MEDSCI 700

: Drug Discovery Biology
2024 Semester One (1243)
Reviews recent studies on the use of chemical and genetic methods to characterise the role of proteins in disease and their potential as drug targets. Topics will include proteins involved in regulation of immune response, lipid mediated cell signalling pathways, drug-protein interactions, some discovery methods, and pre-clinical studies on mechanism of action.
Subject: Medical Science
No pre-requisites or restrictions
10344

MEDSCI 700

: Drug Discovery Biology
2023 Semester One (1233)
Reviews recent studies on the use of chemical and genetic methods to characterise the role of proteins in disease and their potential as drug targets. Topics will include proteins involved in regulation of immune response, lipid mediated cell signalling pathways, drug-protein interactions, some discovery methods, and pre-clinical studies on mechanism of action.
Subject: Medical Science
No pre-requisites or restrictions
10345

MEDSCI 700

: Drug Discovery Biology
2021 Semester One (1213)
Reviews recent studies on the use of chemical and genetic methods to characterise the role of proteins in disease and their potential as drug targets. Topics will include proteins involved in regulation of immune response, lipid mediated cell signalling pathways, drug-protein interactions, some discovery methods, and pre-clinical studies on mechanism of action.
Subject: Medical Science
No pre-requisites or restrictions
10346

MEDSCI 700

: Drug Discovery Biology
2020 Semester Two (1205)
Reviews recent studies on the use of chemical and genetic methods to characterise the role of proteins in disease and their potential as drug targets. Topics will include proteins involved in regulation of immune response, lipid mediated cell signalling pathways, drug-protein interactions, some discovery methods, and pre-clinical studies on mechanism of action.
Subject: Medical Science
No pre-requisites or restrictions
10347

MEDSCI 701

: Special Studies in Medical Science
2024 Semester Two (1245)
The critical review and analysis of research literature relating to a research topic. Components include an extensive literature review article defining the current knowledge relevant to a particular research area, a research proposal outlining proposed Masters research topic and its significance, and a formal presentation of the proposal. Suitable for students intending to undertake a Masters thesis.
Subject: Medical Science
Restriction: MEDSCI 702, 744
10348

MEDSCI 701

: Special Studies in Medical Science
2024 Semester One (1243)
The critical review and analysis of research literature relating to a research topic. Components include an extensive literature review article defining the current knowledge relevant to a particular research area, a research proposal outlining proposed Masters research topic and its significance, and a formal presentation of the proposal. Suitable for students intending to undertake a Masters thesis.
Subject: Medical Science
Restriction: MEDSCI 702, 744
10349

MEDSCI 701

: Special Studies in Medical Science
2023 Semester Two (1235)
The critical review and analysis of research literature relating to a research topic. Components include an extensive literature review article defining the current knowledge relevant to a particular research area, a research proposal outlining proposed Masters research topic and its significance, and a formal presentation of the proposal. Suitable for students intending to undertake a Masters thesis.
Subject: Medical Science
Restriction: MEDSCI 702, 744
10350

MEDSCI 701

: Special Studies in Medical Science
2023 Semester One (1233)
The critical review and analysis of research literature relating to a research topic. Components include an extensive literature review article defining the current knowledge relevant to a particular research area, a research proposal outlining proposed Masters research topic and its significance, and a formal presentation of the proposal. Suitable for students intending to undertake a Masters thesis.
Subject: Medical Science
Restriction: MEDSCI 702, 744